Revise preauthorization laws relating to healthcare

This bill directs Montana's Department of Public Health and Human Services to stop requiring prior authorization for certain FDA-approved antipsychotic drugs used to treat conditions listed in the American Psychiatric Association's Diagnostic and Statistical Manual. Under the new rules, Medicaid providers and patients will no longer need to obtain approval before receiving these specific medications, allowing for faster access to treatment. The changes apply to all claims submitted for services provided on or after the effective date, which is set for 30 days after the bill is passed.